Difference between revisions of "Part:BBa K2926000"
Line 19: | Line 19: | ||
==In vitro Cas13a analysis== | ==In vitro Cas13a analysis== | ||
<hr> | <hr> | ||
− | <div | + | <div> |
In order to ensure the functionality of the Cas13a variants which <a href="https://2019.igem.org/Team:Munich" target="_blank">iGEM Munich</a> kindly provided us, we decided to perform an in vitro analysis of the Cas13a activity. Therefore, we cloned all three Cas systems, Cas13a Lwa, Lbu and Lsh, into pTXB1 and used <i>E.coli ER2566</i> for expression. The protein was purified using the <a href="https://2019.igem.org/wiki/images/8/8a/T--Bielefeld-CeBiTec--ImpactKit_Protocol.pdf" target="_blank"> IMPACT-Kit </a> from NEB. | In order to ensure the functionality of the Cas13a variants which <a href="https://2019.igem.org/Team:Munich" target="_blank">iGEM Munich</a> kindly provided us, we decided to perform an in vitro analysis of the Cas13a activity. Therefore, we cloned all three Cas systems, Cas13a Lwa, Lbu and Lsh, into pTXB1 and used <i>E.coli ER2566</i> for expression. The protein was purified using the <a href="https://2019.igem.org/wiki/images/8/8a/T--Bielefeld-CeBiTec--ImpactKit_Protocol.pdf" target="_blank"> IMPACT-Kit </a> from NEB. | ||
The Bradford assay and a subsequent SDS Page showed that we were able to purify Cas13a Lsh with a molecular weight of 166.2 kDa and a yield of 42.7 µg out of 1.39 g cell mass, Cas13a Lbu with a molecular weight of 138.468 kDa and a yield of 1.09 mg out 1.50 g of purified protein, Cas13a Lwa with a molecular weight of 143.7 kDa and a yield of only 3.1 ng out of 2.11g cultivate. | The Bradford assay and a subsequent SDS Page showed that we were able to purify Cas13a Lsh with a molecular weight of 166.2 kDa and a yield of 42.7 µg out of 1.39 g cell mass, Cas13a Lbu with a molecular weight of 138.468 kDa and a yield of 1.09 mg out 1.50 g of purified protein, Cas13a Lwa with a molecular weight of 143.7 kDa and a yield of only 3.1 ng out of 2.11g cultivate. | ||
</div> | </div> | ||
<!--BILD SDS PAGE MIT MARKIERTEN BANDEN--> | <!--BILD SDS PAGE MIT MARKIERTEN BANDEN--> | ||
− | <div | + | <div> |
<img style="width:400px" src="https://2019.igem.org/wiki/images/6/63/T--Bielefeld-CeBiTec--SDS_Cas_Maldi.png" alt=""> | <img style="width:400px" src="https://2019.igem.org/wiki/images/6/63/T--Bielefeld-CeBiTec--SDS_Cas_Maldi.png" alt=""> | ||
<figcaption>SDS-PAGEof purified Cas13a proteins Lsh, Lbu and Lwa. Marked bands indicate the further used proteins bands for analysis by MALDI-ToF MS/MS.</figcaption> | <figcaption>SDS-PAGEof purified Cas13a proteins Lsh, Lbu and Lwa. Marked bands indicate the further used proteins bands for analysis by MALDI-ToF MS/MS.</figcaption> | ||
Line 30: | Line 30: | ||
</div> | </div> | ||
− | <div | + | <div> |
To further analyze the expressed Cas proteins and compare them to the expected protein sequence, the marked bands were excised from the SDS-PAGE, washed, digested with trypsine and analyzed in a MALDI-ToF MS/MS. The generated mass spectra and mass lists were evaluated using the software BioTools. | To further analyze the expressed Cas proteins and compare them to the expected protein sequence, the marked bands were excised from the SDS-PAGE, washed, digested with trypsine and analyzed in a MALDI-ToF MS/MS. The generated mass spectra and mass lists were evaluated using the software BioTools. | ||
</div> | </div> | ||
− | <div | + | <div> |
− | + | ||
− | <img | + | <img style="width:400px" src="https://2019.igem.org/wiki/images/a/aa/T--Bielefeld-CeBiTec--CeDIS_Maldi_Lsh_Lbu.png" alt=""> |
<figcaption>Mass spectrum of the proteins Cas13a Lbu (1) and Cas13a Lsh (2) after tryptic digestcompared to the theoretical mass spectrum. Excised bands from the SDS-PAGE of Cas13a Lbu and Cas13a Lsh were washed, digested over night with trypsine and co-cristallyzed with a α-Cyano-4-hydoxycinnamic acid-matrix on a MALDI target. The mass spectrum was recorded in a MALDI-ToF MS from Bruker Daltronics and data was evaluated using the software BioTools. </figcaption> | <figcaption>Mass spectrum of the proteins Cas13a Lbu (1) and Cas13a Lsh (2) after tryptic digestcompared to the theoretical mass spectrum. Excised bands from the SDS-PAGE of Cas13a Lbu and Cas13a Lsh were washed, digested over night with trypsine and co-cristallyzed with a α-Cyano-4-hydoxycinnamic acid-matrix on a MALDI target. The mass spectrum was recorded in a MALDI-ToF MS from Bruker Daltronics and data was evaluated using the software BioTools. </figcaption> | ||
</figure> | </figure> | ||
</div> | </div> | ||
− | <div | + | <div> |
Using this technique, we successfully confirmed that Cas13a Lbu and Lsh were expressed and purified from the expression strain. For the Cas13a activity <i>in-vitro</i> assay we designed single guide RNAs (gRNAs) targeting a RFP gene. The following gRNA was ordered via RNA synthesis from IDT. | Using this technique, we successfully confirmed that Cas13a Lbu and Lsh were expressed and purified from the expression strain. For the Cas13a activity <i>in-vitro</i> assay we designed single guide RNAs (gRNAs) targeting a RFP gene. The following gRNA was ordered via RNA synthesis from IDT. | ||
− | <div | + | <div> |
<font style="color:#820933;">CAAAGCTTACGTTAAACACCC</font><font style="color:#888888;">GATTTAGACTACCCCAAAAACGAAGGGGACTAAAAC</font> | <font style="color:#820933;">CAAAGCTTACGTTAAACACCC</font><font style="color:#888888;">GATTTAGACTACCCCAAAAACGAAGGGGACTAAAAC</font> | ||
− | <figure | + | <figure> |
− | <img | + | <img style="width:400px" src="https://2019.igem.org/wiki/images/c/cc/T--Bielefeld-CeBiTec--sgRNA_CasInVitro.png" alt=""> |
</figure> | </figure> | ||
</div> | </div> | ||
Line 51: | Line 51: | ||
</div> | </div> | ||
− | <div | + | <div> |
The target RNA was isolated from an overnight culture of <i>E. coli</i> DH5α with pSB1K3_RFP, purified with the RNA isolation kit from ZYMO Research. The activity of the Cas protein was determined using our <a href="https://2019.igem.org/wiki/images/b/b2/T--Bielefeld-CeBiTec--Cas13a_Assay_Protocol.pdf"> | The target RNA was isolated from an overnight culture of <i>E. coli</i> DH5α with pSB1K3_RFP, purified with the RNA isolation kit from ZYMO Research. The activity of the Cas protein was determined using our <a href="https://2019.igem.org/wiki/images/b/b2/T--Bielefeld-CeBiTec--Cas13a_Assay_Protocol.pdf"> | ||
Cas13a activity assay protocol</a> based on the RNAse Alert-Kit by Thermo Fischer and evaluated via fluorescent measurement with a plate reader. We tested the Cas with the gRNA and the target RNA as well as the Cas and gRNA without the target RNA, to account for any offsite effects. | Cas13a activity assay protocol</a> based on the RNAse Alert-Kit by Thermo Fischer and evaluated via fluorescent measurement with a plate reader. We tested the Cas with the gRNA and the target RNA as well as the Cas and gRNA without the target RNA, to account for any offsite effects. | ||
Due to the low yield we did not conduct the experiment with Lwa. Lbu has been used in a concentration of 2.3 µM, while the concentration of Lsh was 0.08 µM. </div> | Due to the low yield we did not conduct the experiment with Lwa. Lbu has been used in a concentration of 2.3 µM, while the concentration of Lsh was 0.08 µM. </div> | ||
− | <div | + | <div> |
− | <figure | + | <figure > |
− | <img | + | <img style="width:400px" src="https://2019.igem.org/wiki/images/9/96/T--Bielefeld-CeBiTec--CeDIS_inVirtroCas.png" alt=""> |
<figcaption><i>In vitro</i> activity of Cas13a Lsh and Cas13a Lbu using the Cas13a activity array based on the RNAse Alert kit (Thermo Fischer). Development of the fluorescence intensity based on the activity of Cas13a Lbu and Lsh over a period of 12 h. For each Cas variant the activity was measured with all essential parts for the activation of Cas13a including the Cas13a protein, gRNA and the target RNA (for Lsh shown in dark purple and Lbu in dark blue) To show any possible offsite events, the activity was also measured without providing of the target RNA (for Lsh pictured in red and Lbu in light blue). | <figcaption><i>In vitro</i> activity of Cas13a Lsh and Cas13a Lbu using the Cas13a activity array based on the RNAse Alert kit (Thermo Fischer). Development of the fluorescence intensity based on the activity of Cas13a Lbu and Lsh over a period of 12 h. For each Cas variant the activity was measured with all essential parts for the activation of Cas13a including the Cas13a protein, gRNA and the target RNA (for Lsh shown in dark purple and Lbu in dark blue) To show any possible offsite events, the activity was also measured without providing of the target RNA (for Lsh pictured in red and Lbu in light blue). | ||
</figcaption> | </figcaption> |
Revision as of 02:23, 22 October 2019
Cas13a Lsh
This part codes for Cas13a derived from Leptotrichia shahii.
<img style="width:400px" src="" alt=""> <figcaption>SDS-PAGEof purified Cas13a proteins Lsh, Lbu and Lwa. Marked bands indicate the further used proteins bands for analysis by MALDI-ToF MS/MS.</figcaption> </figure>
To further analyze the expressed Cas proteins and compare them to the expected protein sequence, the marked bands were excised from the SDS-PAGE, washed, digested with trypsine and analyzed in a MALDI-ToF MS/MS. The generated mass spectra and mass lists were evaluated using the software BioTools.
<img style="width:400px" src="" alt="">
<figcaption>Mass spectrum of the proteins Cas13a Lbu (1) and Cas13a Lsh (2) after tryptic digestcompared to the theoretical mass spectrum. Excised bands from the SDS-PAGE of Cas13a Lbu and Cas13a Lsh were washed, digested over night with trypsine and co-cristallyzed with a α-Cyano-4-hydoxycinnamic acid-matrix on a MALDI target. The mass spectrum was recorded in a MALDI-ToF MS from Bruker Daltronics and data was evaluated using the software BioTools. </figcaption>
</figure>
Using this technique, we successfully confirmed that Cas13a Lbu and Lsh were expressed and purified from the expression strain. For the Cas13a activity in-vitro assay we designed single guide RNAs (gRNAs) targeting a RFP gene. The following gRNA was ordered via RNA synthesis from IDT.
CAAAGCTTACGTTAAACACCCGATTTAGACTACCCCAAAAACGAAGGGGACTAAAAC <figure> <img style="width:400px" src="" alt=""> </figure>
The target RNA was isolated from an overnight culture of E. coli DH5α with pSB1K3_RFP, purified with the RNA isolation kit from ZYMO Research. The activity of the Cas protein was determined using our <a href="https://2019.igem.org/wiki/images/b/b2/T--Bielefeld-CeBiTec--Cas13a_Assay_Protocol.pdf"> Cas13a activity assay protocol</a> based on the RNAse Alert-Kit by Thermo Fischer and evaluated via fluorescent measurement with a plate reader. We tested the Cas with the gRNA and the target RNA as well as the Cas and gRNA without the target RNA, to account for any offsite effects.
Due to the low yield we did not conduct the experiment with Lwa. Lbu has been used in a concentration of 2.3 µM, while the concentration of Lsh was 0.08 µM.<figure > <img style="width:400px" src="" alt="">
<figcaption>In vitro activity of Cas13a Lsh and Cas13a Lbu using the Cas13a activity array based on the RNAse Alert kit (Thermo Fischer). Development of the fluorescence intensity based on the activity of Cas13a Lbu and Lsh over a period of 12 h. For each Cas variant the activity was measured with all essential parts for the activation of Cas13a including the Cas13a protein, gRNA and the target RNA (for Lsh shown in dark purple and Lbu in dark blue) To show any possible offsite events, the activity was also measured without providing of the target RNA (for Lsh pictured in red and Lbu in light blue). </figcaption>
</figure>
We validated the functionality of both Cas13a Lsh and Lbu. Lsh as well as Lbu show an activity. However, Lsh showed a higher activity than Lbu. Furthermore, the negative controls without any target RNA also showed a slight increase of fluorescence intensity. Thereby, the Lbu negative control showed a higher activity than the Lsh control. The activity without the target RNA present can indicate offsite activity but it can also be influenced by airborne RNAse. As both of the received parts are functional, we performed growth experiments with the complete CeDIS system in pRS304 in S. cerevisea INVSc1. Additionally, we also transformed S. cerevisiae with pRS304 Cas13a Lwa to perform growth experiments and test its functionality.
</html>
Proof of concept: Cas13a as a Cell Death inducing system (CeDIS)
The results of the cultivation with Cas13a Lbu however shows that the cells reach a premature stationary phase. This indicates, that the growth of the yeast is decreased and indicates collateral cleavage events of the Cas13a. Over the duration of 10 hours there is no significant increase in the OD600 of the induced cells carrying the CeDIS. However, the yeast containing the Cas13a show a significant decrease of growth even with the uninduced cells. The control WT S. cerevisiae also shows a difference in growth on raffinose and galactose. The variation of the OD600 for the Cas carrying yeast can be assigned to the variation in carbon source. While these results show that the CeDIS containing Cas13a is active and effective within yeast, it also indicates that there is a background activity when raffinose is used as an inhibitor of the GALL promoter. Even in the uninduced state, Cas is expressed a on a low level , which leads to a decrease in growth, even if it is less effective than in the induced state.
This can potentially be explained by the structure of raffinose. Raffinose is a trisaccharaide consisting of galactose, glucose and fructose.
The tests have been conducted for both Cas13a Lwa and Cas13a Lsh.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 572
Illegal BglII site found at 1118
Illegal BglII site found at 1196
Illegal BglII site found at 1883
Illegal BglII site found at 2771
Illegal BglII site found at 3761 - 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 339
Illegal SapI.rc site found at 664
Illegal SapI.rc site found at 1534
Illegal SapI.rc site found at 2368
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 572
Illegal BglII site found at 1118
Illegal BglII site found at 1196
Illegal BglII site found at 1883
Illegal BglII site found at 2771
Illegal BglII site found at 3761 - 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 339
Illegal SapI.rc site found at 664
Illegal SapI.rc site found at 1534
Illegal SapI.rc site found at 2368